Document |
Document Title |
WO/1996/039405A1 |
Novel pyridiniminyl-1,2-benzisoxazoles and -benzisothiazoles, intermediates and processes for the preparation thereof, and methods of relieving memory dysfunction and treating depression utilizing the 1,2-benzisoxazoles and -benzisothiaz...
|
WO/1996/038144A1 |
Isothiazolones having general structure (I) where A is a monocyclic or bicyclic ring which may contain up to 3 heteroatoms selected from O, S, and N; R1 and R2 are substituent groups such as alkyl, alkoxy, hydroxy, nitro, cyano, amino, a...
|
WO/1996/036615A1 |
Cyclic amides of formula (I) which are useful as fungicides, wherein: A is O; S; N; NR5; or CR14; G is C or N; W is O or S; X is OR1, S(O)mR1 or halogen; R1, R2, and R5 are independently, in part, C1-C6 alkyl; Y is, in part, -O-; -S(O)n-...
|
WO/1996/035669A1 |
Described are (het)aryloxy-, -thio-, aminocrotonates of formula (I) in which the substituents are defined as follows: U is oxygen, sulphur or amino; V is oxygen, sulphur, amino or alkylamino; X, Y, Z, independently of each other, are =N-...
|
WO/1996/033167A1 |
A process for preparing an aromatic or heteroaromatic sulfonyl halide of the general formula (3): Ar-(-SO2Y)n by halogenating an aromatic or heteroaromatic methyl sulfide of the general formula (1): Ar-(-SCH3-mXm)n or an aromatic or hete...
|
WO/1996/032940A1 |
The present invention relates to a series of new N-acylated 4-hydroxyphenylamine derivatives, linked via an alkylene bridge to the nitrogen atom of a 1,2-benzisothiazol-3(2H)-one 1,1-dioxide group, of formula (I), in which n is a number ...
|
WO/1996/029320A1 |
A process for making a 2-alkylbenzisothiazolinone which comprises reacting a bisamide of formula (2) in water or an organic liquid containing water with a bisulphite or bisulphite release agent to form a Bunte salt and converting the Bun...
|
WO/1996/026929A1 |
4-aminotetrahydrobenzisoxazole or -isothiazole compounds having general formulae (Ia) and (Ib), wherein R1-R6, X and P are further defined in the description. The disclosed compounds have GABA (4-aminobutanoic acid) inhibiting activity a...
|
WO/1996/026200A1 |
The invention concerns benzoyl derivatives of formula (I) in which the substituents have the following meanings: L and M represent hydrogen, C1-C6 alkyl, C2-C6 alkenyl, C2-C6 alkinyl, C1-C4 alkoxy (these groups being optionally substitut...
|
WO/1996/026191A1 |
Compounds of formula I, and their N-oxides and agriculturally-suitable salts, are disclosed which are useful as fungicides (I) wherein A is O; S; N; NR5; or CR14. G is C or N; provided that when G is C, A is O, S or NR5 and the floating ...
|
WO/1996/026195A1 |
Novel benzothiazine dioxides which are antagonists of endothelin are described, as well as novel intermediates used in their preparation, methods for the preparation, and pharmaceutical compositions of the same, which are useful in treat...
|
WO/1996/026193A1 |
Phenyldiketone derivatives have the formula (I), in which the substituents have the following meanings: L, M are hydrogen, C1-C6 alkyl, C2-C6 alkenyl, C2-C6 alkinyl, C1-C4 alkoxy optionally substituted by 1 to 5 halogen atoms or C1-C4 al...
|
WO/1996/022978A1 |
Compounds of formula (I) are described, wherein: R1 is CN, CH2CN, CH=CHCN, CHO, or CH=CHCO2H; R2 is aryl lower alkoxy, heteroaryl lower alkoxy, aryl lower alkylthio or heteroaryl lower alkylthio in which each of the aryl and heteroaryl m...
|
WO/1996/022023A1 |
The use of a 2-(C3-5-alkyl)-BIT or 2-aralkyl-BIT such as 2-phenylethyl-BIT as a fungicide for plastics materials. 2-n-butyl-BIT is preferred.
|
WO/1996/021435A1 |
Novel compounds which are effective PDE IV inhibitors are disclosed. The compounds possess improved PDE IV inhibition as compared to theophylline or rolipram as well as with improved selectivity with regard to PDE III inhibition. In cert...
|
WO/1996/021656A1 |
Compounds of formula (I) are useful for treating or preventing obesity, breast cancer, osteoporosis, endometriosis, cardiovascular disease and prostatic disease.
|
WO/1996/019465A1 |
A clathrate compound comprising a tetrakisphenol compound represented by general formula (I) as the host compound and a 2-alkyl-3(2H)-isothiazolone as the guest compound, wherein X represents (CH2)n; n represents 0, 1 or 2; and R1 to R8 ...
|
WO/1996/017834A1 |
A process for producing a 1,2-benzisothiazole by the reaction of a 2-(alkylthio)benzaldehyde oxime with a halogen compound; a process for producing a 3-halo-1,2-benzisothiazole by the reaction of a 1,2-benzisothiazole with a halogenating...
|
WO/1996/016954A1 |
Compounds of formula (I), wherein A is a 5-membered optionally substituted, heteroaryl group comprising at least one hetero atom selected from nitrogen, sulfur and oxygen, which is optionally substituted by one or more of the group R2; R...
|
WO/1996/016034A1 |
A process for producing an aromatic or heteroaromatic thiol represented by the following general formula (2): Ar-(-SH)n by hydrolyzing an aromatic or heteroaromatic halomethyl sulfide represented by the following general formula (1): Ar-...
|
WO/1996/011676A1 |
The invention describes a method of treating neurodegenerative disorders such as Alzheimer's Disease by using a COX-2 inhibitor.
|
WO/1996/010012A1 |
This invention relates to ortho substituted phenyl compounds as inhibitors of prostaglandin synthase, to pharmaceutical compositions comprising such compounds and to methods of using such compounds as antiinflammatory and antipyretic age...
|
WO/1996/005185A1 |
The present invention relates to novel alkylamino derivatives of formula (I). These compounds exhibit a high selectivity and a high affinity for sigma 2 receptor and therefore are useful in the treatment of central nervous system disorde...
|
WO/1996/005184A1 |
The invention pertains to novel herbicidally effective saccharin carboxylic acids or carboxylic acid esters of formula (Ia), in which the substituents are as follows: L, M are hydrogen, C1-C4 alkyl, C1-C4 alkoxy C1-C4 alkylthio, chlorine...
|
WO/1996/005183A1 |
The invention concerns saccharine derivatives of the formula (I) in which the substituents are defined as follows: L, M hydrogen, C1-C4 alkyl, C1-C4 alkoxy, C1-C4 alkylthio, chlorine, cyano, methylsulphonyl, nitro or trifluoromethyl; Z h...
|
WO/1996/005182A2 |
Saccharin derivatives of formula (I) are disclosed, wherein the substituents have the following meanings: L, M stand for hydrogen, alkyl, alkoxy, alkylthio, chlorine, cyano, methylsulphonyl, nitro or trifluoromethyl; Z stands for hydroge...
|
WO/1996/005198A1 |
The invention concerns saccharine derivatives of formula (I) in which the substituents are defined as follows: L, M hydrogen, C1-C4 alkyl, C1-C4 alkoxy, C1-C4 alkylthio, chlorine, cyano, methylsulphonyl, nitro or trifluoromethyl; Z hydro...
|
WO/1996/003380A1 |
The present invention relates to compounds of formula (I), wherein A is an optionally substituted phenyl, naphthyl, pyridyl, pyrazinyl, pyridazinyl, pyrimidyl, thienyl, thiazolyl, oxazolyl, thiadiazolyl having at least two adjacent ring ...
|
WO/1996/002525A1 |
Novel 5HT receptor antagonists of general formula (I) in which Ar1 and Ar2 are an aromatic residue, X is O, NH, CH2O or CH2NH, R1 is hydrogen, a linear or branched alkyl chain comprising 1-6 carbon atoms. The invention also concerns the ...
|
WO/1996/000720A1 |
Compounds of formula (I) wherein R1, R2, R4, R23, R24, R25 and R26 are defined as in the specification. These compounds are useful psychotherapeutics and are potent serotonin (5-HT1) agonists and antagonists.
|
WO/1996/000218A1 |
Novel compounds which are effective PDE IV inhibitors are disclosed. The compounds possess similar or improved PDE IV inhibition as compared to rolipram, with improved selectivity with regard to, e.g., PDE III inhibition. Preferred compo...
|
WO/1995/033746A1 |
Compounds of formula (I) and (II), and their agriculturally-suitable salts, are disclosed which are useful for controlling undesired vegetation, wherein X is a direct bond, O, S, NH, N(C1-C3 alkyl), N(C1-C3 haloalkyl) or N(allyl); R1 is ...
|
WO/1995/031448A1 |
This invention relates to novel N-(5-isothiazolyl)amide compounds of formula (1, 2, or 3), and compositions useful as nematicides, insecticides, miticides, and plant fungicides. The present invention also provides nematicidal, insecticid...
|
WO/1995/030651A1 |
'alpha'-amino acid amides of formula (I), in which n is the number zero or one; R1 is C1-C12alkyl, which is unsubstituted or can be substituted by C1-C4alkoxy, C1-C4alkylthio, C1-C4alkylsulfonyl, C3-C8cycloalkyl, cyano, C1-C6alkoxycarbon...
|
WO/1995/026959A1 |
A novel alkylenediamine derivative having the effect of inhibiting dysuria occuring under a high intravesical pressure and represented by general formula (1) wherein R1 represents hydrogen, alkyl, halogen, haloalkyl, hydroxy, alkoxy, nit...
|
WO/1995/025727A1 |
Naphthylamides are described, as well as methods for the preparation and pharmaceutical composition of same, which are useful as central nervous system agents and are particularly useful as antipsychotic agents and as agents for the trea...
|
WO/1995/024403A1 |
A compound of formula (I), or a salt thereof, wherein n is 0, 1 or 2; and R is a group of formulae (II) to (XXI), wherein: the S(O)nCH2CH2CH=CF2 group is at least one of R1 (when attached to a carbon atom), R2, R3, R4, R5 or R6; R1 (when...
|
WO/1995/021153A1 |
Phenyl acetic acid derivatives of formula (I) in which the components and index have the following meanings: X is NOCH3, CHOCH3 CHCH3 and CHCH2CH3; R1 is hydrogen and alkyl; R2 is cyano, nitro, trifluoro methyl, halogen, alkyl and alkoxy...
|
WO/1995/020578A1 |
This invention is directed to compounds of formula (I), wherein R1 is an optionally substituted lower alkyl group; R2 is an optionally substituted oxaaliphatic group; R3 is an optionally substituted aryl group or an optionally substitute...
|
WO/1995/020014A1 |
A process for colouring a synthetic textile material or fibre blend thereof which comprises applying to the synthetic textile material a compound or mixture thereof, which is free from water solubilising groups, of the Formula (1) A-N=N-...
|
WO/1995/018799A1 |
The invention encompasses the novel compound of Formula (I) useful in the treatment of cyclooxygenase-2 mediated diseases. The invention also encompasses certain pharmaceutical compositions for treatment of cyclooxygenase-2 mediated dise...
|
WO/1995/018797A1 |
Isothiazolidin-3-one-1,1 dioxide, 3-oxo-1,2,5-thiadiazolidine-1,1-dioxide and derivatives thereof, reduce or inhibit the activity of serine proteases. Such compounds are useful as anti-inflammatory and anti-metastatic agents.
|
WO/1995/018111A1 |
This invention relates to novel compounds containing basic and acidic termini, pharmaceutical compositions containing such compounds, processes for preparing such compounds, and to methods of using these compounds, alone or in combinatio...
|
WO/1995/015309A1 |
Compounds selected from those of general formula [A-B (Groups I and II)] and (group III), (1, 2 and 3) where B is (4) and A is selected from specified aminoacyl compounds are inhibitors of DP-IV mediated processes.
|
WO/1995/014009A1 |
Cyclic amides of Formula (I) which are useful as fungicides wherein: A is O; S; N; NR5; or CR14; G is C or N; W is O or S; X is OR1, S(O)mR1 or halogen; R1, R2, and R5 are independently, in part, C1-C6 alkyl; Y is, in part, -O-; -S(O)n-;...
|
WO/1995/013262A1 |
Compounds of formula (I) are described wherein R1 is hydrogen, -(lower alkyl)q(CO2R6 or OH), -CN, -C(R7)=NOR8, NO2, -O(lower alkyl)R9, -CC-R10, -CR11=C(R12)(R13), -C(=O)CH2C(=O)CO2H, -CO(R14), alkylthio, alkylsulphinyl, alkylsulphonyl, c...
|
WO/1995/012587A1 |
2-Aminocarboxylic acid compounds substituted with 5-arylisoxazol-4-yl or 5-arylisothiazol-4-yl and having general formula (I), wherein A is a bond or a spacer group; B is a group -CH(NR'R'')-COOH wherein R' and R'' are independently hydr...
|
WO/1995/011680A1 |
Heteroarylpiperidines, pyrrolidines, and piperazines are useful as antipsychotic and analgesic agents. The compounds are especially useful for treating psychoses by administering to a mammal a psychoses-treating effective amount of one o...
|
WO/1995/011278A1 |
Diphenylamines have formula (I), in which the ring A may be benzoanellated; D stands for an aryl radical or for a five-membered aromatic heterocyclic residue that has 1 to 3 heteroatoms in the heterocyclic ring selected from the group th...
|
WO/1995/010507A1 |
Compounds are disclosed having the formula (I), as well as their salts, as they are defined in the first claim. In the formula (I), R1 stands for CO-Q-R8, in which R8 = H or R; R2, R3 stand for H or (C1-C4)alkyl; R4 stands for H, R, RO, ...
|